Jeff Yass’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-43,034
Closed -$508K – 14551
2026
Q2
$549K Buy
43,034
+13,455
+45% +$174K ﹤0.01% 9695
2026
Q1
$407K Sell
29,579
-83
-0.3% -$1.28K ﹤0.01% 10166
2025
Q4
$463K Buy
29,662
+20,912
+239% +$386K ﹤0.01% 8974
2025
Q3
$211K Sell
8,750
-258
-3% -$9.6K ﹤0.01% 10878
2025
Q2
$324K Buy
+9,008
New +$236K ﹤0.01% 10164
2022
Q2
– Hold
0
– -$6K – 13949
2022
Q1
– Hold
0
– – – 12804
2021
Q4
– Hold
0
– – – 12605
2021
Q2
– Sell
-1
Closed -$1.01M – 13265
2021
Q1
$1.01M Buy
+1
New +$765K ﹤0.01% 7713
2020
Q3
– Hold
0
– -$13K – 11150
2020
Q2
– Hold
0
– – – 9960
2020
Q1
– Hold
0
– – – 10078
2019
Q4
– Hold
0
– -$11K – 10647
2019
Q3
– Hold
0
– – – 10011
2019
Q2
– Hold
0
– – – 10041
2018
Q3
– Hold
0
– -$220K – 10244
2018
Q2
– Hold
0
– – – 8445
2017
Q4
– Hold
0
– -$207K – 9906
2017
Q3
– Hold
0
– – – 7966
2017
Q2
– Hold
0
– – – 7113
2017
Q1
– Hold
0
– – – 5635
2016
Q4
– Hold
0
– – – 9486
2016
Q3
– Hold
0
– – – 8260
2015
Q4
– Hold
0
– – – 9983
2015
Q3
– Hold
0
– – – 8909
2014
Q4
– Hold
0
– -$147K – 10102
2014
Q3
– Hold
0
– – – 8905

Other funds holding TNXP

Jeff Yass's TNXP Position: Q3 2026 in Review

Jeff Yass sold out of Tonix Pharmaceuticals (TNXP) in Q3 2026, closing a stake of 43,034 shares — an estimated $508K sold.

Jeff Yass first reported a position in TNXP in Q1 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2021. 113 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Jeff Yass reported no remaining Tonix Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 43,034 Tonix Pharmaceuticals shares in Q3 2026, an estimated $508K.
  • Jeff Yass first reported a position in Tonix Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Jeff Yass's Tonix Pharmaceuticals position peaked at $1.01M in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.